UnitedHealth Group to Discuss Business Outlook at Investor Conference
November 27 2017 - 4:15PM
Business Wire
UnitedHealth Group (NYSE: UNH) will host its annual Investor
Conference with analysts and institutional investors in New York
City on Tuesday, November 28, 2017, beginning at 8:00 a.m. EST. At
the meeting, senior leaders will discuss the Company’s strategy,
performance and outlook, including reviewing trends and initiatives
related to its various businesses.
The Company will host a livestream of the presentation and
management question and answer portions of this meeting and will
make available a digital package of conference materials on its
Investors page at www.unitedhealthgroup.com. A replay of the
conference will be available on the Company web site through
January 2, 2018.
In conjunction with the meeting, the Company will discuss its
financial outlook. Revenues for 2017 are expected to exceed $200
billion, with net earnings to approach $9.45 per share and adjusted
net earnings to approach $10.00 per share, consistent with the
Company’s most recent outlook provided with its third quarter 2017
earnings release. Adjusted net earnings exclude from net earnings
only the non-cash amortization expense pertaining to
acquisition-related intangible assets.
UnitedHealth Group will also introduce its 2018 outlook,
including revenues of $223 billion to $225 billion, net earnings of
$10.00 to $10.30 per share, and adjusted net earnings of $10.55 to
$10.85 per share. Cash flows from operations are expected to range
from $13.3 billion to $13.8 billion in 2018.
About UnitedHealth
GroupUnitedHealth Group (NYSE: UNH) is a diversified
health and well-being company dedicated to helping people live
healthier lives and helping make the health system work better for
everyone. UnitedHealth Group offers a broad spectrum of products
and services through two distinct platforms: UnitedHealthcare,
which provides health care coverage and benefits services; and
Optum, which provides information and technology-enabled health
services. For more information, visit UnitedHealth Group at
www.unitedhealthgroup.com or follow @UnitedHealthGrp on
Twitter.
Non-GAAP Financial
InformationThis news release presents non-GAAP financial
information provided as a complement to the results provided in
accordance with accounting principles generally accepted in the
United States of America (“GAAP”). Adjusted net earnings exclude
amortization expense of approximately $0.90 and $0.85 per share and
the related tax impact of $0.35 and $0.30 per share for the years
ended December 31, 2017 and 2018, respectively, pertaining to
acquisition-related intangible assets.
Forward-Looking
StatementsThe statements, estimates, projections,
guidance or outlook contained in this document include
“forward-looking” statements within the meaning of the Private
Securities Litigation Reform Act of 1995 (PSLRA). These statements
are intended to take advantage of the “safe harbor” provisions of
the PSLRA. Generally the words “believe,” “expect,” “intend,”
“estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,”
“should” and similar expressions identify forward-looking
statements, which generally are not historical in nature. These
statements may contain information about financial prospects,
economic conditions and trends and involve risks and uncertainties.
We caution that actual results could differ materially from those
that management expects, depending on the outcome of certain
factors.
Some factors that could cause actual results to differ
materially from results discussed or implied in the forward-looking
statements include: our ability to effectively estimate, price for
and manage our medical costs, including the impact of any new
coverage requirements; new laws or regulations, or changes in
existing laws or regulations, or their enforcement or application,
including increases in medical, administrative, technology or other
costs or decreases in enrollment resulting from U.S., Brazilian and
other jurisdictions’ regulations affecting the health care
industry; the outcome of the Department of Justice’s legal actions
relating to risk adjustment submission matters; our ability to
maintain and achieve improvement in CMS star ratings and other
quality scores that impact revenue; reductions in revenue or delays
to cash flows received under Medicare, Medicaid and other
government programs, including the effects of a prolonged U.S.
government shutdown or debt ceiling constraints; changes in
Medicare, including changes in payment methodology, the CMS star
ratings program or the application of risk adjustment data
validation audits; cyber-attacks or other privacy or data security
incidents; failure to comply with privacy and data security
regulations; regulatory and other risks and uncertainties of the
pharmacy benefits management industry; competitive pressures, which
could affect our ability to maintain or increase our market share;
changes in or challenges to our public sector contract awards; our
ability to execute contracts on competitive terms with physicians,
hospitals and other service providers; failure to achieve targeted
operating cost productivity improvements, including savings
resulting from technology enhancement and administrative
modernization; increases in costs and other liabilities associated
with increased litigation, government investigations, audits or
reviews; failure to manage successfully our strategic alliances or
complete or receive anticipated benefits of acquisitions and other
strategic transactions; fluctuations in foreign currency exchange
rates on our reported shareholders’ equity and results of
operations; downgrades in our credit ratings; the performance of
our investment portfolio; impairment of the value of our goodwill
and intangible assets if estimated future results do not adequately
support goodwill and intangible assets recorded for our existing
businesses or the businesses that we acquire; failure to maintain
effective and efficient information systems or if our technology
products do not operate as intended; and our ability to obtain
sufficient funds from our regulated subsidiaries or the debt or
capital markets to fund our obligations, to maintain our debt to
total capital ratio at targeted levels, to maintain our quarterly
dividend payment cycle or to continue repurchasing shares of our
common stock.
This list of important factors is not intended to be exhaustive.
We discuss certain of these matters more fully, as well as certain
risk factors that may affect our business operations, financial
condition and results of operations, in our filings with the
Securities and Exchange Commission, including our annual reports on
Form 10-K, quarterly reports on Form 10-Q and current reports on
Form 8-K. Any or all forward-looking statements we make may turn
out to be wrong, and can be affected by inaccurate assumptions we
might make or by known or unknown risks and uncertainties. By their
nature, forward-looking statements are not guarantees of future
performance or results and are subject to risks, uncertainties and
assumptions that are difficult to predict or quantify. Actual
future results may vary materially from expectations expressed or
implied in this document or any of our prior communications. You
should not place undue reliance on forward-looking statements,
which speak only as of the date they are made. We do not undertake
to update or revise any forward-looking statements, except as
required by applicable securities laws.
Click here to subscribe to Mobile Alerts for UnitedHealth
Group.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171127005875/en/
UnitedHealth GroupBrett Manderfeld, 952-936-7216Vice
PresidentorJohn S. Penshorn, 952-936-7214Senior Vice
PresidentorMedia:Tyler Mason, 424-333-6122Vice President of
Communications
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Aug 2024 to Sep 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Sep 2023 to Sep 2024